|Articles|September 1, 2019
- Pharmaceutical Executive-09-01-2019
- Volume 39
- Issue 9
Pharmaceutical Executive, September 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec's 18th Annual Industry Auditover 6 years ago
Product Development: The Optimizer’s Curseover 6 years ago
Setting Your Launch Pathover 6 years ago
Pre-launch Prep: The Modern Protocolover 6 years ago
The Murky Outlook for Generic Drugsover 6 years ago
Post-Launch Birthday: The Time to Refineover 6 years ago
Product Launch: Five Paths Forwardover 6 years ago
Once Upon a Brandover 6 years ago
Country Report: Chinaover 6 years ago
Other Products to WatchNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5